Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520988 · ClinicalTrials.gov registry record · NA
Improving Blood Pressure in Colorado
A NA study of Hypertension, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
- 3
- Study locations
NCT00520988: Completed NA study of Hypertension, sponsored by Kaiser Permanente.
NCT00520988 is a NA study of Hypertension that has completed, run by Kaiser Permanente. The registered enrollment target is 290 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00520988, a NA study of Hypertension, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
- 3
- Study locations
Study Summary
We will improve hypertension control in Colorado by implementing a population-based intervention using interactive voice response (IVR) technology that will be delivered to patients in three healthcare systems across Colorado (Denver Health and Hospitals \[DH\], VA Colorado Healthcare System \[VA\], and Kaiser Permanente of Colorado \[KPCO\]). Together, these organizations serve over 1 million Coloradans. The IVR-based hypertension program will: 1) reach out to more patients using fewer resources than a traditional patient visit approach, 2) implement evidence based guidelines for therapy, 3) facilitate patients' acquisition of medications by allowing them to order and receive medications at home, and 4) enhance medication adherence using tailored educational and motivational messages. HYPOTHESES: 1. A sizable population of patients is at high risk for further cardiovascular morbidity and mortality, based on uncontrolled hypertension. 2. An IVR-centered intervention among patients with diagnosed but uncontrolled hypertension is feasible. 3. An IVR-centered intervention plus usual care for these patients improves BP control, compared to usual care alone.
Conditions Studied
Interventions
- BEHAVIORAL Use of telephone-based Interactive Voice Recognition system
Study Locations (3)
Colorado
- Denver Health Medical Center - Denver
- Denver VA Medical Center - Denver
- Kaiser Permanente Colorado - Metro Denver Area
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2006-03 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT00520988 record still lists
NCT00520988 is an interventional study that assigns participants to a tested intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Use of telephone-based Interactive Voice Recognition system is the first listed.
NCT00520988 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00520988 about?
NCT00520988 is a clinical study titled "Improving Blood Pressure in Colorado". We will improve hypertension control in Colorado by implementing a population-based intervention using interactive voice response (IVR) technology that will be delivered to patients in three healthcare systems across Colorado (Denver Health and Hospitals \[DH\], VA Colorado Healthcare System \[VA\],...
What is the current status of trial NCT00520988?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2006-03. Estimated completion is 2011-09.
What conditions does trial NCT00520988 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT00520988?
The interventions under investigation include: Use of telephone-based Interactive Voice Recognition system (BEHAVIORAL).
Who is sponsoring clinical trial NCT00520988?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00520988 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00520988's enrollment target sits among peer trials
290 183rd of 470 higher than 288 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia